Literature DB >> 16532040

Uveitis screening: HLAB27 antigen and ankylosing spondylitis in a New Zealand population.

Rachael Niederer1, Helen Danesh-Meyer.   

Abstract

AIMS: To establish rates of HLAB27-positive uveitis and ankylosing spondylitis in a New Zealand population and to examine characteristics of patients with ankylosing spondylitis that present with uveitis.
METHODS: A retrospective audit of 124 consecutive patients presenting to the Acute Eye Clinic at Auckland City Hospital with a diagnosis of either bilateral uveitis or their second episode of uveitis was undertaken. All patients underwent full blood count, erythrocyte sedimentation rate, HLAB27 typing, and radiographs of the sacroiliac joints and lumbar spine.
RESULTS: The HLAB27 antigen was detected in 36% of patients undergoing uveitis screening tests. Ankylosing spondylitis was diagnosed on lumbar spine and sacroiliac joint X-ray in 41% of HLAB27-positive patients and in none of the HLAB27-negative patients. No correlation was identified between age at first presentation and diagnosis of ankylosing spondylitis. Ankylosing spondylitis was not associated with elevated white cell count or erythrocyte sedimentation rate. Male gender and detection of the HLAB27 antigen were strongly associated with a diagnosis of ankylosing spondylitis (p<0.001).
CONCLUSIONS: Ankylosing spondylitis was detected in 41% of the HLAB27-positive patients and in 0% of the HLAB27-negative patients. Routine lumbar spine and sacroiliac joint X-rays are only recommended for HLAB27-positive patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16532040

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  8 in total

1.  Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis.

Authors:  Allison R Loh; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2010-10       Impact factor: 5.258

Review 2.  Gender disparities in ocular inflammatory disorders.

Authors:  Hatice Nida Sen; Janet Davis; Didar Ucar; Austin Fox; Chi Chao Chan; Debra A Goldstein
Journal:  Curr Eye Res       Date:  2014-07-02       Impact factor: 2.424

3.  Long term complications and vision loss in HLA-B27 uveitis.

Authors:  Haya H Al-Ani; Joanne L Sims; Rachael L Niederer
Journal:  Eye (Lond)       Date:  2022-08-29       Impact factor: 4.456

4.  Systemic associations of anterior uveitis in a tertiary care ophthalmic centre in south India.

Authors:  Gaurav Mathur; Jyotirmay Biswas
Journal:  Int Ophthalmol       Date:  2012-05-09       Impact factor: 2.031

5.  Intravitreal Triamcinolone Acetonide for Macular Edema in HLA-B27 Negative Ankylosing Spondylitis.

Authors:  M M Moschos; Z Gatzioufas; I Margetis
Journal:  Case Rep Ophthalmol       Date:  2010-12-04

6.  The association of human leukocyte antigen B27 with anterior uveitis in patients from the western region of Saudi Arabia: a retrospective study.

Authors:  Ahmed M Bawazeer; Heba Ismail Joharjy
Journal:  Clin Ophthalmol       Date:  2013-10-30

7.  Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity.

Authors:  Rebecca L Roberts; Mary C Wallace; Gregory T Jones; Andre M van Rij; Tony R Merriman; Andrew Harrison; Douglas White; Lisa K Stamp; Daniel Ching; John Highton; Simon M Stebbings
Journal:  Arthritis Res Ther       Date:  2013-10-22       Impact factor: 5.156

8.  Isolation of IgG antibodies to Toxocara in ankylosing spondylitis patients with acute anterior uveitis.

Authors:  Francisco-Javier Jiménez-Balderas; Janete García-Jaimes; Rita Ríos; Abraham Zonana-Nacach; Raquel Tapia-Romero; Nayeli Villanueva; Patricia Méndez-Samperio; Jorge-Luis de-la-Rosa-Arana
Journal:  Korean J Ophthalmol       Date:  2014-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.